|
Read more ›› |
By: PR Newswire Association LLC. - 04 Dec 2024
|
Related companies:
Foresee Pharmaceuticals Co., Ltd. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Dec 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 02 Dec 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 28 Nov 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 27 Nov 2024
|
Related companies:
Lin BioScience, Inc. |
Lin-Zhi International, Inc. |
Shanghai Pan-Lin Asset Management Co., Ltd. (Also Known as Fortune United Partners, Panlin Capital) |
Guang Dong Shuang Lin Bio-Pharmacy Co., Ltd |
|
|
Read more ›› |
By: GlobeNewswire - 26 Nov 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 19 Nov 2024
|
Related companies:
Health2Sync |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 19 Nov 2024
|
Related companies:
TAHO Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 15 Nov 2024
|
Related companies:
Foresee Pharmaceuticals Co., Ltd. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 13 Nov 2024
|
Related companies:
Caliway Biopharmaceuticals Co., Ltd. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 12 Nov 2024
|
Related companies:
GlycoNex, Inc. |
GlycoNex Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 12 Nov 2024
|
Related companies:
Caliway Biopharmaceuticals Co., Ltd. |
|
|
Read more ›› |
By: GlobeNewswire - 04 Nov 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 04 Nov 2024
|
Related companies:
Formosa Biomedical Technology Corp. |
Formosa Laboratories, Inc. |
Formosa Pharmaceuticals |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 01 Nov 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 29 Oct 2024
|
Related companies:
GlycoNex, Inc. |
GlycoNex Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 25 Oct 2024
|
Related companies:
Bora Pharmaceuticals |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 10 Oct 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 05 Oct 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 30 Sep 2024
|
|
|
|